What is a mood stabilizer?

Psychological Medicine

Volumn 37, Issue 5, 2007, Pages 609-614

  Goodwin, Guy M ^a   Malhi, Gin S ^b  

^a WARNEFORD HOSPITAL   (United Kingdom)

^b UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; CHLORPROMAZINE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; LITHIUM SALT; MOOD STABILIZER; OLANZAPINE; PLACEBO; QUETIAPINE; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID;

BIPOLAR DEPRESSION; BIPOLAR I DISORDER; BIPOLAR II DISORDER; CLINICAL TRIAL; DRUG EFFICACY; DRUG MECHANISM; DRUG RESPONSE; DRUG SAFETY; EDITORIAL; ELECTROCONVULSIVE THERAPY; EPILEPSY; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MANIA; METABOLIC DISORDER; NONHUMAN; PRACTICE GUIDELINE; RAPID CYCLING BIPOLAR DISORDER; SECONDARY PREVENTION;

AFFECT; ANTICONVULSANTS; ANTIPSYCHOTIC AGENTS; HUMANS; MENTAL DISORDERS; PRACTICE GUIDELINES; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 34047161021     PISSN: 00332917     EISSN: 14698978     Source Type: Journal    
DOI: 10.1017/S0033291706009305     Document Type: Editorial

References (25)

1. Bauer, M. S. & Mitchner, L. (2004). What is a 'mood stabilizer'? An evidence-based response. American Journal of Psychiatry 161, 3-18.
2. Calabrese, J. R., Bowden, C. L., Sachs, G., Yatham, L. N., Behnke, K., Mehtonen, O.-P., Montgomery, P., Ascher, J., Paska, W., Earl, N. & Deveaugh-Geiss, J. (2003). Aplacebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. Journal of Clinical Psychiatry 64, 1013-1024.
3. Calabrese, J. R., Keck Jr., P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E. & Mullen, J. (2005a). A randomised, double-blind, placebocontrolled trial of quetiapine in the treatment of bipolar I or II depression. American Journal of Psychiatry 162, 1351-1360.
4. Calabrese, J. R., Shelton, M. D., Rapport, D. J., Youngstrom, E. A., Jackson, K., Bilali, S., Ganocy, S. J. & Findling, R. L. (2005b). A 20-month, double-blind, maintenance trial of lithium versus divalproex in rapid-cycling bipolar disorder. American Journal of Psychiatry 162, 2152-2161.
5. Calabrese, J. R., Suppes, T., Bowden, C. L., Sachs, G. S., Swann, A. C., McElroy, S. L., Kusumakar, V., Ascher, J. A., Earl, N. L., Greene, P. L. & Monaghan, E. T. (2000). A doubleblind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder. Journal of Clinical Psychiatry 61, 841-850.
6. Carroll, L. (1998). Alice's Adventures in Wonderland; and, Through the Looking-Glass and What Alice Found There. Oxford University Press: Oxford.
7. Colom, F., Vieta, E., Martinez-Aran, A., Reinares, M., Goikolea, J. M., Benabarre, A., Torrent, C., Comes, M., Corbella, B., Parramon, G. & Corominas, J. (2003). A randomized trial on the efficacy of group psychoeducation in the prophylaxis of recurrences in bipolar patients whose disease is in remission. Archives of General Psychiatry 60, 402-407.
8. Dunner, D. L. & Fieve, R. R. (1974). Clinical factors in lithium carbonate prophylaxis failure. Archives of General Psychiatry 30, 229-233.
9. Frances, A., Docherty, J. & Kahn, D. (1996). Treatment of bipolar disorder. Journal of Clinical Psychiatry 57, 5-58.
10. Frances, A. J., Kahn, D. A., Carpenter, D., Docherty, J. P. & Donovan, S. L. (1998). The Expert Consensus guidelines for treating depression in bipolar disorder. Journal of Clinical Psychiatry 59, 73-79.
11. Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., Rush, A. J. & Weissman, M. M. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder. Remission, recovery, relapse, and recurrence. Archives of General Psychiatry 48, 851-855.
12. Frye, M. A., Ketter, T. A., Leverich, G. S., Huggins, T., Lantz, C., Denicoff, K. D. & Post, R. M. (2000). The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. Journal of Clinical Psychiatry 61, 9-15.
13. Geddes, J. R., Burgess, S., Hawton, K., Jamison, K. & Goodwin, G. M. (2004). Long-term lithium therapy for bipolar disorder: Systematic review and meta-analysis of randomized controlled trials. American Journal of Psychiatry 161, 217-222.
14. Goodwin, G. M. (1994). Recurrence of mania after lithium withdrawal. Implications for the use oflithium in the treatment of bipolar affective disorder. British Journal of Psychiatry 164, 149-152.
15. Goodwin, G. M. & Consensus Group of the British Association for Psychopharmacology (2003). Evidence-based guidelines for treating bipolar disorder: Recommendations from the British Association for Psychopharmacology. Journal of Psychopharmacology 17, 149-173.
16. Harwood, A. J. & Agam, G. (2003). Search for a common mechanism of mood stabilizers. Biochemical Pharmacology 66, 179-189.
17. Laborit, H., Huguenard, P. & Alluaume, R. (1952). A new vegetative stabilizer [in French]. Presse Medicale 60, 206-208.
18. Lam, D. H., Watkins, E. R., Hayward, P., Bright, J., Wright, K., Kerr, N., Parr-Davis, G. & Sham, P. (2003). A randomized controlled study of cognitive therapy for relapse prevention for bipolar affective disorder: outcome of the first year. Archives of General Psychiatry 60, 145-152.
19. Malhi, G. S., Berk, M., Bourin, M., Ivanovski, B., Dodd, S., Lagopoulos, J. & Mitchell, P. B. (2005). A typical mood stabilizers : A 'typical' role for atypical antipsychotics. Acta Psychiatrica Scandinavica 111, 29-38.
20. Okuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A. & Watanabe, M. (1979). Comparison of the antimanic efficacy of carbamazepine and chlorpromazine: A double-blind controlled study. Psychopharmacology 66, 211-217.
21. Okuma, T., Inanaga, K., Otsuki, S., Sarai, K., Takahashi, R., Hazama, H., Mori, A. & Watanabe, S. (1981). A preliminary double-blind study on the efficacy of carbamazepine in prophylaxis of manic-depressive illness. Psychopharmacology 73, 95-96.
22. Post, R. M., Uhde, T. W., Ballenger, J. C. & Squillace, K. M. (1983). Prophylactic efficacy of carbamazepine in manic-depressive illness. American Journal of Psychiatry 140, 1602-1604.
23. Scott, J., Paykel, E., Morris, R., Bentall, R., Kinderman, P., Johnson, T., Abbott, R. & Hayhurst, H. (2006). Cognitive behavioural therapy for severe and recurrent bipolar disorders : Randomised controlled trial. British Journal of Psychiatry 188, 313-320.
24. Tohen, M., Marneros, A., Bowden, C. L., Greil, W., Koukopoulos, A., Belmaker, H., Jacobs, T., Baker, R., Williamson, D., Evans, A., Dossenbach, M. & Cassano, G. (2003). Olanzapine vs. lithium in relapse prevention in bipolar disorder: A randomized double-blind controlled 12-month clinical trial. Bipolar Disorders 5, 89.
25. Tohen, M., Sanger, T. M. & McElroy, S. L. (1999). Olanzapine versusplacebo in the treatment of acute mania. American Journal of Psychiatry 140, 1602-1604.